Patent · US Active

Conjugate of biotin-modified dimer and phthalocyanine dye

US12115223B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignees

THE UNIVERSITY OF TOKYO · JP
SAVID THERAPEUTICS INC. · JP

Inventors

Motomu Kanai · Bunkyo, JP
Kenzo YAMATSUGU · Tokyo, JP
Toshifumi TATSUMI · Tokyo, JP
Kazuki TAKAHASHI · Tokyo, JP
Tatsuhiko Kodama · Zushi, JP
Akira SUGIYAMA · Tokyo, JP
Takefumi YAMASHITA · Tokyo, JP
Masanobu TSUKAGOSHI · Tokyo, JP
Yuzo Toda · Asaka, JP
Junji Nishigaki · Toyokawa, JP

Key dates

Filing date	Apr 22, 2021
Grant date	Oct 15, 2024
Priority date	—
Expiry date	Apr 22, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/6898
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

[Object] It is an object of the present invention to provide a conjugate of a biotin-modified dimer and a phthalocyanine dye, which is used in photoimmunotherapy.[Means for Solution] A compound represented by the following formula (1) or a salt thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.